Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy

Podobne zapisy

• Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
  od: Li, Xianjun, i wsp.
  Wydane: (2020)
• CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
  od: Schlafstein, Ashley J., i wsp.
  Wydane: (2018)
• Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
  od: Zhao, Yue, i wsp.
  Wydane: (2019)
• Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
  od: Garufi, Giovanna, i wsp.
  Wydane: (2023)
• Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer
  od: Silva, Leonardo Roberto da, i wsp.
  Wydane: (2019)